| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.25B | 28.07B | 24.39B | 22.73B | 21.14B | 24.18B |
| Gross Profit | 7.99B | 7.82B | 5.28B | 5.00B | 4.96B | 8.31B |
| EBITDA | 3.48B | 3.30B | 2.06B | 1.70B | 2.48B | 2.44B |
| Net Income | 4.74B | 4.72B | -703.00M | 700.00M | 1.82B | 1.02B |
Balance Sheet | ||||||
| Total Assets | 83.59B | 83.33B | 82.25B | 70.28B | 70.87B | 74.15B |
| Cash, Cash Equivalents and Short-Term Investments | 5.42B | 7.19B | 6.61B | 7.25B | 10.53B | 5.95B |
| Total Debt | 9.65B | 9.20B | 12.96B | 10.82B | 11.59B | 12.67B |
| Total Liabilities | 27.87B | 28.41B | 31.18B | 25.70B | 26.15B | 27.88B |
| Stockholders Equity | 55.72B | 54.91B | 51.07B | 44.64B | 44.71B | 46.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 714.00M | -1.31B | -2.77B | 1.39B | 1.99B |
| Operating Cash Flow | 0.00 | 4.24B | 2.90B | -85.00M | 2.63B | 3.28B |
| Investing Cash Flow | 0.00 | 960.00M | -3.61B | 1.21B | -532.00M | -1.19B |
| Financing Cash Flow | 0.00 | -4.37B | 1.72B | -1.25B | -1.67B | -893.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥49.98B | 13.94 | ― | 1.51% | 5.86% | 57.87% | |
76 Outperform | ¥230.99B | 12.35 | 13.33% | 3.47% | 4.21% | 23.86% | |
72 Outperform | ¥78.08B | 6.88 | ― | 1.55% | 5.78% | 14.23% | |
72 Outperform | ¥31.57B | 10.02 | ― | 1.23% | 6.74% | 29.20% | |
69 Neutral | ¥55.22B | 20.67 | ― | 4.63% | 7.74% | 0.96% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | ¥63.66B | 14.49 | ― | 1.14% | 8.17% | 10.65% |